Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
22.68
+0.36 (1.61%)
Apr 1, 2025, 2:45 PM CST
SHE:002262 Revenue
In the year 2024, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.70B CNY with 13.01% growth. Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.55B in the quarter ending December 31, 2024, with 12.03% growth.
Revenue
5.70B
Revenue Growth
+13.01%
P/S Ratio
3.96
Revenue / Employee
961.95K
Employees
5,394
Market Cap
22.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.70B | 656.13M | 13.01% |
Dec 31, 2023 | 5.04B | 742.99M | 17.28% |
Jan 1, 2023 | 4.30B | 362.85M | 9.22% |
Jan 1, 2022 | 3.94B | 574.36M | 17.09% |
Dec 31, 2020 | 3.36B | -788.01M | -18.99% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |